Hypertension is one of the most commonly known systemic risk factor, affecting more than 1 billion people worldwide. [1] [2] [3] Although high blood pressure (BP) can cause stroke, several prospective cohort studies have provided compelling data suggesting that during middle age, high BP is also associated with an increased risk of late-life cognitive impairment and dementia. [4] [5] [6] [7] Furthermore, hypertension has profound effects on eye structure and function because the retinal, choroidal, and optic nerve vasculature undergo a series of pathophysiological changes in response to increased BP, resulting in a range of clinical signs referred to as hypertensive retinopathy, hypertensive choroidopathy, and hypertensive optic neuropathy. 2 Although many studies have reported a positive association between systemic hypertension and retinal or choroidal vascular disease, to our knowledge, few reports have been published regarding the relationship between systemic hypertension and ocular neurological functions such as color vision, which is also very important to quality of life. Thus, in this study, we investigated whether middle-age BP levels are associated with acquired color vision impairment (ACVI).
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METHODS

Study population and design
The present Okubo Color Study was designed to evaluate the relationship between color vision function (in particular, ACVI) and ophthalmological disease, cardiovascular risk factors, and lifestyle factors. This study was reviewed by the National Defense Medical College Ethics Board (Tokorozawa, Saitama, Japan) to ensure that it met ethical guidelines, and all subjects provided written informed consent according to the Declaration of Helsinki before being enrolled in the study. The detailed study design has been described previously. [8] [9] [10] In brief, this study was a survey of the prevalence of ACVI among male officials aged 20-60 years who were on active duty in the Japanese Self Defense Force, Okubo Garrison, Kyoto, Japan. All subjects underwent annual health examinations between April 2005 and March 2006 at the Okubo Garrison. Information was obtained on past and current diseases, medication use, and personal physical records of each subject. The subjects also answered structured questionnaires designed to examine lifestyle characteristics and gave detailed interviews. In addition, all subjects underwent color vision testing, visual acuity measurement, slit-lamp biomicroscopic examination, intraocular pressure measurement with noncontact applanation tonometry, fundus examination and photography, and venous blood examination. Color vision was tested using the Ishihara pseudoisochromatic plates (Kanehara Shuppan, Tokyo, Japan) for assessment of congenital color vision impairment (CCVI) and Lanthony 15-hue desaturated panel (D-15 DS) plates (Luneau, Paris, France), for assessment of ACVI. The readers of retina photographs and examiners of color vision tests were blinded to clinical information.
BP measurement
BP was measured in the morning by 1 of 2 trained examiners. After emptying their bladders, the subjects were seated for 5 minutes with their feet flat on the floor in a quiet room, with no physical activity, eating, drinking, or smoking during the preceding 3 hours. BP was measured with an appropriate-sized cuff placed on the left arm (the midpoint of the length of the cuff was placed over the brachial artery and the midpoint of the height of the cuff was at the heart level) using a random-zero sphygmomanometer; Korotkoff sounds I and V were criteria for systolic BP (SBP) and diastolic BP (DBP), respectively. We measured BP twice only and used the average of the 2 measurements in these analyses. BP levels (mm Hg) were categorized according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines for BP 11 as follows: normal = SBP <120 and DBP <80 mm Hg; prehypertension = SBP 120-139 and DBP 80-89 mm Hg; stage 1 hypertension = SBP 140-159 and DBP 90-99 mm Hg; and stage 2 hypertension = SBP ≥160 and DBP ≥100 mm Hg.
Cardiovascular risk factor definition
After overnight fasting, venous blood was drawn to measure fasting plasma glucose, total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein cholesterol, and glycated hemoglobin (HbA1c) levels, which were standardized in accordance with the Japan Diabetes Society guidelines. All subject information was blinded to the examiners and photograph readers, including diagnosis at referral, ophthalmological and systemic status, and lifestyle characteristics.
Diabetes was defined as a fasting glucose level of ≥7.0 mmol/L (126 mg/dl), HbA1c level of ≥48 mmol/L, or the use of insulin or oral hypoglycemic medications. 12 In accordance with the Japan Atherosclerosis Society guidelines, 13 
Smoking and alchohol status
The subjects were categorized into never smokers, ever smokers, current smokers, and past smokers. Current and past smokers were defined as present and past habitual smokers who had smoked for ≥1 year, respectively. The subjects who had been smoking for <1 year or <1 packyear were considered to be never smokers. Those who had given up smoking for >10 years were considered to be ever smokers. Never and ever smokers were considered to be nonsmokers. Smokers were evaluated by pack-years of smoking. Alcohol consumption was classified on the basis of the frequency of alcohol consumption (daily, weekly, monthly, or less often).
Cataract grading
To grade the cataract level, ophthalmologists used slitlamp examination, which was performed on the basis of Lens Opacity Classification System III (LOCS III) standard color photographs 14 and the Wilmer classification. 15 We defined the presence of a nuclear cataract in at least 1 eye with a nuclear opacity of grade 3.0 or greater on LOCS III. Cortical and posterior subcapsular cataracts were considered to be present when opacity of grades 1 or 2 or greater, respectively, was observed on the Wilmer classification.
Glaucoma definition
The subjects were recruited for visual field evaluation if the intraocular pressure was >20 mm Hg or if color fundus photography showed abnormalities, including glaucomatous optic disc appearance and a nerve fiber layer defect. Visual field testing was performed with static perimetric analysis using the Humphrey Field Analyzer, 30-2 Swedish Interactive Threshold Algorithm standard program (Humphrey Instruments, San Leandro, CA), or the Octopus 301 full-threshold G1 program version 2.04 (Interzeag, Schlieren, Switzerland). A final diagnosis of glaucoma was made on the basis of optic disc appearance, intraocular pressure, and the results of visual field testing and clinical records, which included physical records and completed lifestyle questionnaires.
Age-related macular degeneration grading
Each color fundus photograph was graded on the basis of a comparison with standard photographs according to the Rotterdam Study. 16 These photographs were classified as normal, early age-related maculopathy (stage 2 or 3), or agerelated macular degeneration.
Inclusion and exclusion criteria
To be included in the study, the subjects had to have a score of ≥0.8 best-corrected visual acuity on the decimal visual acuity chart, which led to the exclusion of 73 subjects from the analyses. The subjects who had undergone cataract or retinal surgery or those who had any corneal or retinal disease, including age-related macular degeneration, central serous chorioretinitis, diabetic retinopathy, or retinal/vitreous hemorrhage, were excluded (n = 6 subjects). Those who had previously taken or were currently taking systemic medication such as digitalis glycosides, antiepileptic drugs, antimalarial drugs, and antituberculosis drugs 17 were excluded (n = 4 subjects) to avoid the possibility of side effects of these medications on color vision. Moreover, 75 subjects who failed the Ishihara plate test, those with a pattern typical of congenital deutan or protan defects on testing with SPP2 or D-15 DS, or those with a history of CCVI in their medical history records (for whom the results of color testing had been recorded on enlistment) were excluded. In questionable cases, anomaloscopy was performed. The subjects who failed more than one major crossing using D-15 DS were classified as ACVI 15-hue patients. Subsequently, these patients underwent the Farnsworth-Munsell 100-hue test, which was performed monocularly at a distance of 300 mm, with the subjective near refraction placed in a trial frame. In accordance with the results of Verriest et al., 18 the subjects with scores less than the age-specific 95th percentile were diagnosed through the Farnsworth-Munsell 100-hue test as having ACVI (ACVI 100-hue). In addition, 12 subjects who declined to undergo the Farnsworth-Munsell 100-hue test were excluded. The study criteria and excluded participants are summarized in Figure 1 .
Statistical analysis
Baseline characteristics were reported as means ± standard deviation or counts and proportion, as appropriate. Differences between subjects with and without ACVI were evaluated using the unpaired t test for continuous variables and Fisher exact test for categorical variables.
Multiple logistic regression analysis was performed to examine the relationship between BP levels and ACVI prevalence. Three models were used to assess whether this relationship was independent of other confounding factors that might affect color vision. Model 1 was adjusted for age, smoking status (pack-years), and alcohol status; model 2 was adjusted for age, smoking status (pack-years), alcohol status, and eyerelated disorders (cataract and glaucoma); and model 3 was adjusted for age, smoking status (pack-years), alcohol status, eye-related disorders, and cardiovascular-related risk factors (LDL cholesterol, HbA1c, and body mass index). We selected these adjusting factors according to past reports (models 1 and 2) 6,19-22 and additionally added cardiovascular risk factors (model 3). The goodness-of-fit of these models were tested using the Hosmer-Lemeshow test. In accordance with our previous reports, 8, 9 the impacts of interaction between BP and LDL cholesterol and between BP and HbA1c on ACVI were also analyzed. Moreover, we performed sensitivity analysis on ACVI 15-hue patients, excluding subjects with diabetes, cataract, and glaucoma. Furthermore, to exclude the possible effects of hypertensive medications on color vision, we performed sensitivity analyses on the subjects and excluded those prescribed antihypertensive drugs. Individuals, rather than eyes, were the units of analysis because the right and left eyes were not examined independently. A subject was considered to have CCVI or ACVI when it occurred in either eye. P < 0.05 was considered statistically significant. All statistical analyses were performed with SAS version 9.3 software (SAS Institute, Cary, NC).
RESULTS
Of 1,152 potential study subjects, 1,042 met the enrollment criteria, yielding an overall inclusion rate of 90.5%. Of the enrolled subjects, 872 (83.7%) were eligible for this study, 130 were diagnosed as ACVI 15-hue patients, and 31 failed the Farnsworth-Munsell100-hue test. The demographic and medical characteristics of the BP categories are shown in Table 1 . Figure 2 is a box plot of BP distribution in each color vision category; it shows that differences in BP values were significant between groups (analysis of variance, P < 0.05). As shown in Table 2 , the prevalence of ACVI 100-hue patients significantly increased with increasing BP category. Odds ratios (ORs) for the basic model (model 1) and full model (model 3) for subjects with stage 2 hypertension were 8.32 (95% confidence interval (CI) = 2.12-30.53) and 7.13 (95% CI = 1.72-27.88), respectively, compared with those for the subjects with normal BP. Tests for trend were significant in all of the models. Table 3 shows ORs with 95% CIs for the ACVI 15-hue patients in relation to BP level. This table shows that each 10-mm Hg increase in SBP and DBP was related to 20% and 21% higher odds with the ACVI 15-hue patients, respectively. ORs for models 1 and 3 for the subjects with stage 2 hypertension were 4.93 (95% CI = 1.94-12.20) and 4.37 (95% CI = 1.69-11.03), respectively, compared with those for the subjects with normal BP. The impacts of interaction between BP and LDL cholesterol and between BP and HbA1c on ACVI 100-hue and ACVI 15-hue patients were not significant. Sensitivity analysis on ACVI 15-hue patients, excluding subjects with diabetes, cataract, and glaucoma, showed similar results. The Hosmer-Lemeshow test demonstrated that all models excluding model 3 of DBP (P = 0.02) were not significant. These results showed these models have a good fit on the data. Furthermore, to exclude the possible effects of hypertensive medications on color vision, we performed sensitivity analyses on the subjects and excluded those prescribed antihypertensive drugs. Both sensitivity analyses showed similar results in all of the models (data not shown).
DISCUSSION
After adjusting for systemic parameters such as body mass index, LDL choresterol, HbA1c, and other ophthalmic diseases, a significant relationship was identified between BP levels and ACVI prevalence.
To our knowledge, there is no strong evidence indicating an association between BP levels and ACVI. Although a possible relationship between the color arrangement test score and hypertension has been reported previously, 23 this previous study was less reliable than our study because of its small sample size and methodological problems.
ACVI occurs in a variety of patient populations in association with ocular diseases (senile cataract, age-related macular degeneration, cone degeneration, optic neuritis, and glaucoma) and the use of certain medications (antiepileptic, antimalarial, and antituberculosis drugs). Thus, multivariable analysis adjusted for these reported risk factors, [19] [20] [21] [22] as well as the strict differential diagnosis criteria between the presence or absence of ACVI, support the robustness of our study. In general, ACVI grading is difficult because the reference score contains a wide range of variation within a normal population. 6 Although the Farnsworth-Munsell 100-hue test and age-specific criteria of Verriest et al. 18 remain the gold standard for ACVI diagnosis, these criteria cannot be used for grading purposes. Although the Verriest criteria are more stringent than the D-15 DS test to confirm ACVI, D-15DS has also been used for the evaluation of ACVI 17 because the Farnsworth-Munsell 100-hue test is very time consuming. D-15DS was designed specifically for ACVI 6 and suited to identify mild acquired impairments in another past study. 24 Thus, ACVI patients were diagnosed in accordance with the Verriest criteria (first endpoint, ACVI 100-hue) and with D-15DS test (second endpoint, ACVI 15-hue). We confirmed a positive correlation between BP levels and color vision impairment in both analyses. Because the eye is unique in that it allows direct observation of hypertensive sequelae of the microvasculature in vivo, the association between hypertension and the eye mainly focuses on structural changes such as vascular changes and hemorrhages. 25 Classically, increased BP results in a series of retinal microvascular changes called hypertensive retinopathy. Although increased BP can also have a pronounced impact on ocular structure and has been linked to a wide range of eye diseases, 2,26-29 most previous studies largely focused on structural changes and visual function was limited to assessing visual acuity or field. Color vision discrimination ability is an important ocular function, and its deterioration (referred to as ACVI) is generally thought to be an early indicator of various neurotoxic and neurodegenerative diseases. 6, 24 Although a detailed mechanism remains unclear, there are several possibilities that may account for our findings.
Many reports provide substantial evidence of a risk effect of high middle-age BP on the development of late-life neurological degeneration related to cognitive impairment and Alzheimer's disease. 5, 30, 31 Autopsy and neuroimaging data from this study could also confirm this association by linking increased numbers of neuritic plaques, neurofibrillary tangles, and hippocampal atrophy to high middle-age BP. 32 The autoregulation of cerebral blood flow is thought to be impaired in individuals with SBP >150 mm Hg. 33 Hypertension affects neurovascular coupling, leading to decreased perfusion, and is associated with microvascular disease, cognitive decline, and dementia. 31 Qiu et al. 5 suggested 2 possible biological pathways that link middle-age hypertension to dementia: atherosclerotic and hemodynamic mechanisms. These epidemiological and pathological findings, which indicate that increased BP may cause functional changes in the retina and higher visual Unless otherwise noted, values are means ± SD, or, in case of skewed distributions, data are medians (25th percentile-75th percentile). Baseline characteristics were compared with the unpaired t test for normal distributed variables or Wilcoxon rank sum test for non-normal distributed variables between acquired color vision impairment (ACVI) and no ACVI. P values are derived from the Student t test for data normally distibuted or, in case of skewed distributions, from the Mann-Whitney U test. Categorical variables such as proportions were analyzed using the Pearson χ 2 test or Fisher exact test as appropriate. BP status was defined as follows: normal = systolic blood pressure (SBP) <120 and diastolic blood pressure (DBP) <80 mm Hg; prehypertension = SBP 120-139 and DBP 80-89 mm Hg; stage 1 hypertension = SBP 140-159 and DBP 90-99; and stage 2 hypertension = SBP ≥160 and DBP ≥100 mm Hg.
Abbreviations: ACVI 100-hue, acquired color vision impairment diagnosed by the Farnsworth-Munsell 100-hue test; ACVI 15-hue, acquired color vision impairment diagnoses by the Lanthony 15-hue desaturated panel plates; BMI, body mass index; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; HT, hypertension; LDL, low-density lipoprotein; NA, not applicable; SBP, systolic blood pressure.
pathways as a result of impaired endothelial dysfunction, neurovascular coupling, or other effects on the ocular capillaries or neurons, 31 do not contradict the results of the present study. Other sensory dysfunctions, such as hearing loss, were also reported, and their impairment was associated with Alzheimer's disease and cognitive impairment in the Framingham Heart Study Cohort, 34 which found that Alzheimer's disease and hearing dysfunction patients have similar abnormalities, such as midbrain plaques and tangles. Thus, the Framingham Study findings may support the hypothesis that sensory organ dysfunction may be sensitive to injury and precede the emergence of cognitive decline and dementia.
Clinical dementia is the end of a process that begins many years before the condition is diagnosed. Thus, early diagnosis is crucial for treatment and prevention. Deterioration of color discrimination ability has long been recognized as an impairment that can precede the onset of clinically detectable neurological changes. [8] [9] [10] [11] Previous studies have reported that Alzheimer's disease patients make significantly more errors in various color vision tests than normal control subjects. 35, 36 Thus, ACVI due to middle-age hypertension may be linked to early subclinical neurological symptoms in lateonset neurodegenerative diseases such as cognitive impairment and Alzheimer's disease.
Nevertheless, these relationships remain hypothetical 28 because of the long latency period between the apparent cause and effect.
There were several possible limitations in our study. First, although our findings suggested that there were significant correlations between ACVI prevalence and high BP levels during middle age, the etiology and detailed mechanisms are yet to be clearly elucidated. The second limitation was related to the design of the study, which was cross-sectional; therefore, the long-term changes in BP levels and associated time points for the incidence of ACVI could not be determined. Therefore, to assess the causal relationship between BP levels and the incidence of ACVI, a longitudinal approach should be used. Moreover, we measured BP only twice during 1 visit. Ideally, BP measurements should be performed on both arms initially with the arm with the highest BP used thereafter, at least three measurements should be made, and the average of the last two measurements should be used. Hypertension should be diagnosed on more than a single occasion and with multiple BP assessments. The third limitation was that the study population, which consisted entirely of healthy Japanese middle-age men aged 20-60 years old, could have potentially restricted the external validity of the study. However, the prevalence of ACVI 100-hue that was determined for the 40-year age span of the subjects was approximately 4.5%, which appears to be similar to the results reported by Verriest et al. 18 Fourth, a considerable number of subjects were excluded from the analysis, mainly because of CCVI and low visual acuity, which may have affected the results, although such subjects were also excluded from the analyses in many other studies. 6, 17 Thus, the high participation rate (90.3%), low missing data, eligibility criteria used, and diagnosis method support the internal validity of this study. Fifth, the 95% CI values of ORs in the ACVI 100-hue analysis had wide ranges because of the relatively low number of cases. To definitely confirm the results of this study, a prospective larger cohort study using a more generalized population should be conducted. Finally, because this was a cross-sectional study, a recall bias could have affected the results. Despite these limitations, the data are useful and important for further investigations of many of these associations.
In conclusion, the findings of this cross-sectional study indicate that high middle-age BP levels in men are positively correlated with the prevalence of ACVI, which is one of the earliest indicators of neurological degeneration.
